Atopic Dermatitis (Eczema) clinical trials at UC Davis
2 research studies open to eligible people
A Study of the Experimental Medicine Baricitinib (LY3009104) in Adults With Moderate to Severe Atopic Dermatitis
open to eligible people ages 18 years and up
The purpose of this study is to evaluate the efficacy and safety of baricitinib in adult participants with moderate to severe atopic dermatitis.
Sacramento, California and other locations
“What dose of probiotics helps with gut bacteria in infants?”
open to all eligible people
The purpose of this study is to investigate the dose of a probiotic supplement (Bifidobacterium longum subsp. infantis) required to achieve predominant gut colonization in healthy newborn, breastfed infants. The study will also examine whether supplementation with this probiotic can reduce the chance of developing eczema and food allergies in enrolled infants.